Public-Health-Sensitive Policy Measures and Patent Laws, published by the Third World Network.

Contents

1. Overcoming the TRIPS Restriction on Pharmaceutical Imports by and Exports to
   Countries with Insufficient Manufacturing Capacity
    
   (a) Background to the "Paragraph 6" issue in the Doha Declaration on the TRIPS Agreement and Public Health
   (b) Problem of countries with insufficient or no manufacturing capacities
   (c) In search of a solution
   (d) The Decision and Statement
    
2. Conditions and Measures for Implementing the Waiver to the TRIPS Restriction
    
   (a) Countries and situations where the waiver is not required
   (b) General situation where the waiver is required
   (c) Measures required by the importing country
    
3. Measures Required by the Exporting Country
    
   (a) Notify the WTO
   (b) Conditions of the compulsory licence
   (c) Payment of compensation
   (d) Regional arrangements
    
4. Additional Requirements under the WTO General Council Chairperson's Statement
    
5. Comment on the 'Dampening Effect' of the Conditions and Procedures in the Decision and Chairperson's Statement
    
6. Limited Area of Applicability of the Decision
    
7. Conclusions 

References